NorthWest Biotherapeutics Inc (NWBO)

[TZOR]

They will manipulate, that is what they do. I thought this part was refreshing,

For the six months ended June 30, 2015, the Company made net disbursements to Cognate of approximately $21.3 million (with invoices generally paid all in cash rather than half in cash and half in stock), including charges relating to manufacturing for both the Phase III and Phase I/II clinical trials, ongoing product and process development, and expansion of several Company programs under these service agreements. With the substantial expansion of recruitment in the Phase III DCVax-L trial during this period, patient volume has exceeded the maximum amount contracted for, and as a result the disbursements have included excess production costs. In addition, the disbursements have included preparatory work for multiple different Phase II clinical trials, which the Company anticipates launching during the second half of this year, as well as development work connected with new intellectual property and certain regulatory requirements. The disbursements have also included substantial one-time services related to manufacturing expansion in Europe.